Application of EGFR inhibitor reduces circulating tumor cells during transcatheter arterial embolization
Crossref DOI link: https://doi.org/10.1007/s12094-017-1761-8
Published Online: 2017-10-11
Published Print: 2018-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Zhu, L.
Liu, R. http://orcid.org/0000-0002-3561-3187
Zhang, W.
Qian, S.
Wang, J.
License valid from 2017-10-11